Literature DB >> 21139705

Hypoxia-inducible factor and vascular endothelial growth factor in the neuroretina and retinal blood vessels after retinal ischemia.

Gisela Håkansson, Bodil Gesslein, Lotta Gustafsson, Ulrica Englund-Johansson, Malin Malmsjö.   

Abstract

Retinal ischemia arises from circulatory failure. As the retinal blood vessels are key organs in circulatory failure, our aim was to study the retinal vasculature separately from the neuroretina to elucidate the role of hypoxia-inducible factor (HIF) 1α and 1β and vascular endothelial growth factor (VEGF) in retinal ischemia. Retinal ischemia was induced in porcine eyes by applying an intraocular pressure, followed by 12 h of reperfusion. HIF-1α mRNA expression was not affected by ischemia, while immunofluorescence staining was higher after ischemia in the neuroretina. HIF-1β immunoreactivity and mRNA expression were unaffected. VEGF protein levels in the vitreous humor and VEGF staining in the neuroretina were more pronounced in eyes subjected to ischemia than in the sham eyes. VEGF may be activated downstream of HIF-1 and is known to stimulate retinal neovascularization, which causes sight-threatening complications. These results emphasize the need for pharmacological treatment to block the HIF and VEGF signaling pathways in retinal ischemia.

Entities:  

Keywords:  Blood vessels; Hypoxia-inducible factor; Ischemia; Porcine; Retina; Vascular endothelial growth factor

Year:  2010        PMID: 21139705      PMCID: PMC2956450          DOI: 10.1007/s12177-010-9050-6

Source DB:  PubMed          Journal:  J Ocul Biol Dis Infor        ISSN: 1936-8437


  25 in total

1.  Glial cell reactivity in a porcine model of retinal detachment.

Authors:  Ianors Iandiev; Ortrud Uckermann; Thomas Pannicke; Antje Wurm; Solveig Tenckhoff; Uta-Carolin Pietsch; Andreas Reichenbach; Peter Wiedemann; Andreas Bringmann; Susann Uhlmann
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

2.  Characterization of vasomotion in porcine retinal arterioles.

Authors:  Anders Hessellund; Peter Jeppesen; Christian Aalkjaer; Toke Bek
Journal:  Acta Ophthalmol Scand       Date:  2003-06

Review 3.  Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors.

Authors:  Olli Arjamaa; Mikko Nikinmaa
Journal:  Exp Eye Res       Date:  2006-06-05       Impact factor: 3.467

Review 4.  Ocular neovascularization: basic mechanisms and therapeutic advances.

Authors:  Michael Dorrell; Hannele Uusitalo-Jarvinen; Edith Aguilar; Martin Friedlander
Journal:  Surv Ophthalmol       Date:  2007-01       Impact factor: 6.048

Review 5.  Use of isolated ocular arteries in vitro to define the pathology of vascular changes in glaucoma.

Authors:  C H Buckley; P W Hadoke; C J O'Brien
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

Review 6.  Pharmacotherapy for diabetic retinopathy.

Authors:  Grant M Comer; Thomas A Ciulla
Journal:  Curr Opin Ophthalmol       Date:  2004-12       Impact factor: 3.761

Review 7.  Hypoxia-specific gene expression for ischemic disease gene therapy.

Authors:  Hyun Ah Kim; Ram I Mahato; Minhyung Lee
Journal:  Adv Drug Deliv Rev       Date:  2009-04-23       Impact factor: 15.470

8.  N-methyl-D-aspartic acid causes relaxation of porcine retinal arterioles through an adenosine receptor-dependent mechanism.

Authors:  Kim Holmgaard; Christian Aalkjaer; John D C Lambert; Toke Bek
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-16       Impact factor: 4.799

9.  Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.

Authors:  E A Pierce; R L Avery; E D Foley; L P Aiello; L E Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

View more
  5 in total

1.  Baicalein protects against retinal ischemia by antioxidation, antiapoptosis, downregulation of HIF-1α, VEGF, and MMP-9 and upregulation of HO-1.

Authors:  Hsiao-Ming Chao; Min-Jay Chuang; Jorn-Hon Liu; Xiao-Qian Liu; Li-Kang Ho; Wynn H T Pan; Xiu-Mei Zhang; Chi-Ming Liu; Shen-Kou Tsai; Chi-Woon Kong; Shou-Dong Lee; Mi-Mi Chen; Fang-Ping Chao
Journal:  J Ocul Pharmacol Ther       Date:  2013-03-28       Impact factor: 2.671

2.  Co-culture of Retinal and Endothelial Cells Results in the Modulation of Genes Critical to Retinal Neovascularization.

Authors:  Ravindra Kumar; Sandra Harris-Hooker; Ritesh Kumar; Gary Sanford
Journal:  Vasc Cell       Date:  2011-11-23

3.  Silver and gold nanoparticles exposure to in vitro cultured retina--studies on nanoparticle internalization, apoptosis, oxidative stress, glial- and microglial activity.

Authors:  Erika Söderstjerna; Patrik Bauer; Tommy Cedervall; Hodan Abdshill; Fredrik Johansson; Ulrica Englund Johansson
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

4.  Xue-fu-Zhu-Yu decoction protects rats against retinal ischemia by downregulation of HIF-1α and VEGF via inhibition of RBP2 and PKM2.

Authors:  Shu-Qiu Tan; Xue Geng; Jorn-Hon Liu; Wynn Hwai-Tzong Pan; Li-Xiang Wang; Hui-Kang Liu; Lei Hu; Hsiao-Ming Chao
Journal:  BMC Complement Altern Med       Date:  2017-07-14       Impact factor: 3.659

5.  Inflamed In Vitro Retina: Cytotoxic Neuroinflammation and Galectin-3 Expression.

Authors:  Patrik Maximilian Bauer; Marina Castro Zalis; Hodan Abdshill; Tomas Deierborg; Fredrik Johansson; Ulrica Englund-Johansson
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.